Fierce Healthcare January 19, 2022
Heather Landi

Nationally, more than 95% of all positive COVID-19 cases are presumed to be the omicron variant, according to data collected and tracked by Walgreens from positive tests at its 5,000 drug stores.

The company teamed up with Aegis Sciences to use the lab testing company’s data to develop a new interactive tracking tool that uniquely identifies the spread of current and emerging variants in near real time.

“Data regarding spread of variants is important to our understanding of viral transmission and, as new variants emerge, it will be critical to continue to track this information quickly to predict which communities are most at risk,” said Matthew Hardison, M.D., senior vice president of lab operations at Aegis Sciences, in a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
New AI drug discovery powerhouse Xaira rises with $1B in funding
AI-enabled drug discovery company Xaira launches with $1B
25 most expensive hospital drugs
Independent Pharmacies Must Look Out For Deceptive PBM Practices

Share This Article